ARCHIVES

Iressa Authorization In Europe Clarifies Differences Between U.S., E.U. Standards

This article is from The Cancer Letter archive.

Vol. 35 No. 30 | July 31, 2009

Download PDF Visit The Full Archive

Related Articles

FDA Approves Lapatinib For Advanced Breast Cancer

March 30, 2007

CDC To Award $23 Mil. To States for Screening

April 26, 1991

Phase III Trial Would Give Clearer Picture Of C225 Role.

February 15, 2002

New Tool Found To Cut DNA At Any Position

April 4, 1986

Nutrition Program Announcement Lists Suggested Areas For Research

September 22, 1978

Other Contract Concepts Approved By DCE Board

March 10, 1989